Cow's Milk Allergy Clinical Trial
Verified date | May 2016 |
Source | Federico II University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ethics Committee |
Study type | Observational |
Epigenetic mechanisms have been implicated in the pathogenesis of food allergy. The
investigators previously demonstrated that tolerance acquisition in children with
Immunoglobulin E- (IgE) mediated cow's milk allergy (CMA) is driven by epigenetic modulation
of the Th1 and Th2 cytokine genes. A regulatory T cell (Treg) suppressive phenotype,
characterized by stable expression of the transcription factor "Forkhead box Protein 3"
(FoxP3), plays a pivotal role in food tolerance. FoxP3 mRNA expression is lower in children
with atopic asthma or IgE-mediated food allergy than in healthy children. FoxP3 stable
expression requires full CpG demethylation of its transcriptional regulatory regions, and,
moreover, hypermethylation of the FoxP3 gene has been associated with reduced Treg function
and allergy.
DNA methylation is a biologically and chemically stable epigenetic modification that locks
in long-term gene expression patterns. The demethylation status of FoxP3 at a highly
conserved region within the Treg-specific-demethylated-region (TSDR), a CpG-rich, located on
the 2nd conserved non-coding sequence of FoxP3 (CNS2), is restricted to Tregs.
Transcriptional activity of the TSDR is essentially determined by its methylation status :
it is completely inactive in its methylated state, but when the TSDR is demethylated,
transcription factors such as Ets-1 and Creb can bind to the TSDR. TSDR demethylated and
open chromatin conformation in the Foxp3 locus leads to stable phenotype differentiated
Foxp3+ Treg. FoxP3 TSDR demethylation in peripheral blood mononuclear cells (PBMCs) has been
associated with reduced atopic sensitization and asthma in children. Epigenetic regulation
of antigen-induced T-cell subsets may predict a state of immune tolerance in food allergy.
Indeed, DNA methylation of the FoxP3 gene in Tregs decreased during oral tolerance
acquisition in patients with peanut allergy undergoing oral immunotherapy. The aim of this
study was to evaluate further the epigenetic regulation of FoxP3 gene in children with
IgE-mediated CMA.
Status | Completed |
Enrollment | 40 |
Est. completion date | April 2014 |
Est. primary completion date | April 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 3 Months to 18 Months |
Eligibility |
Inclusion Criteria: - IgE-mediated CMA children (aged 3 to 18 months) Exclusion Criteria: - allergic disorders or food allergies other than cow's milk allergy - eosinophilic disorders of the gastrointestinal tract - food protein-induced enterocolitis syndrome - concomitant chronic systemic diseases - congenital cardiac defects - active tuberculosis - autoimmune diseases - immunodeficiency - chronic inflammatory bowel diseases - celiac disease - cystic fibrosis - metabolic diseases - lactose intolerance - malignancy - chronic pulmonary diseases - malformations of the gastrointestinal tract |
Observational Model: Case-Crossover, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
Italy | University of Naples Federico II | Naples |
Lead Sponsor | Collaborator |
---|---|
Federico II University |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | DNA demethylation (rate, in %) of the Treg-specific-demethylated-region (TSDR) of FoxP3 | At enrollment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02738060 -
The Effect of Baked Milk on Cow's Milk Allergy
|
Phase 2 | |
Recruiting |
NCT02149134 -
Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy
|
Phase 2 | |
Recruiting |
NCT01891916 -
Effect Of Lactobacillus GG on Atopic March
|
N/A | |
Completed |
NCT01622426 -
Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy
|
N/A | |
Completed |
NCT01634490 -
Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy
|
N/A | |
Completed |
NCT02466035 -
Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA)
|
N/A | |
Completed |
NCT02379598 -
Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy
|
N/A | |
Completed |
NCT04330092 -
Diagnosis of Cow's Milk Protein Allergy
|
||
Not yet recruiting |
NCT02081651 -
Parmigiano-Reggiano Cheese as a Possible Strategy to Acquire Oral Tolerance in Children With Cow's Milk Allergy
|
Phase 3 | |
Completed |
NCT03462030 -
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
|
Phase 2 | |
Completed |
NCT02465905 -
Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : "Petit Lait" Study
|
N/A | |
Suspended |
NCT05731206 -
Hypoallergenicity of a Hydrolyzed Protein Infant Formula
|
N/A | |
Not yet recruiting |
NCT06456541 -
Infant Formula in Infants and Children With Cow's Milk Allergy
|
N/A | |
Recruiting |
NCT02062476 -
Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy
|
Phase 2 | |
Completed |
NCT01589731 -
Polymerized Beta-lactoglobulin Comparative Immunoreactivity
|
N/A | |
Terminated |
NCT02405923 -
Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy
|
N/A | |
Terminated |
NCT04910373 -
Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy
|
N/A | |
Recruiting |
NCT01968278 -
Use of Baked Milk in Oral Immunotherapy for Severe IgE-mediated Cow's Milk Protein Allergic Patients
|
N/A | |
Withdrawn |
NCT01470768 -
Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas
|
N/A | |
Recruiting |
NCT05883384 -
Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein Alergy
|